Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors.
CONCLUSION: Our results strongly support the value of miR-122 as potential biomarker of liver injury and probably prognosis. Nevertheless, the value of miR-122 in prediction of prognosis of HCC patients was limited to certain patients' subgroups. Since circulating miR-122 may be influenced by impaired renal function, AFP and hemoglobin concentration, those factors need to be considered while interpreting miR-122 level.
PMID: 31933516 [PubMed - in process]
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Franck M, Schütte K, Malfertheiner P, Link A Tags: World J Gastroenterol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Children | Cirrhosis | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | Laboratory Medicine | Liver | Liver Cancer | Liver Disease | Statistics | Study | Urology & Nephrology